Patents by Inventor Franz Rovensky

Franz Rovensky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline form of morphine-6-glucuronide
    Patent number: 6172206
    Abstract: A new crystalline form of morphine-6-glucuronide, referred to as Form A, characterized by its infrared spectrum pattern and/or by its x-ray powder diffraction image, the use thereof and a process for the preparation thereof.
    Type: Grant
    Filed: November 4, 1999
    Date of Patent: January 9, 2001
    Assignee: CeNeS Ltd.
    Inventors: Herwig Schneider, Rudolph Franzmair, Andreas Koch, Franz Rovensky
  • Novel basic-substituted 5-halo-thienoisothiazol-3(2H)-one 1,1-dioxides, a process for the preparation thereof, and pharmaceutical preparations containing these compounds
    Patent number: 4929616
    Abstract: The invention relates to a novel basic-substituted 5-halo-thienoisothiazol-3(2H)-one 1,1-dioxide of the formula ##STR1## in which R.sub.1 denotes hydrogen, (C.sub.1 -C.sub.4)-alkyl or halogen,R.sub.2 denotes halogen, andn denotes an integer from 2 to 6, the pharmaceutically acceptable acid-addition salt thereof, a process for their preparation, and their use in medicament for the treatment of anxiety states.
    Type: Grant
    Filed: February 6, 1989
    Date of Patent: May 29, 1990
    Assignee: Chemisch Pharmazeutische Forschungsgesellschaft
    Inventors: Dieter Binder, Franz Rovensky
  • Novel 2-thienyloxyacetic acid derivatives, a process for their preparation and pharmaceutical preparations containing them
    Patent number: 4877809
    Abstract: The invention relates to novel 2-thienyloxyacetic acid derivatives of the general formula ##STR1## in which R denotes a phenyl or thienyl group which is optionally mono- or polysubstituted by halogen, trifluoromethyl or C.sub.1 -C.sub.4 alkyl, and pharmaceutically usable salts thereof, a process for the preparation of these compounds and their use for the treatment of thromboses, inflammations, high blood pressure, apoplexy and angina pectoris.
    Type: Grant
    Filed: March 29, 1988
    Date of Patent: October 31, 1989
    Assignee: CL Pharma Aktiengesellschaft
    Inventors: Dieter Binder, Franz Rovensky, Hubert P. Ferber